The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 4, 2008, Pages 459-467

  Lazǎr, Daniela ^a   Tǎban, Sorina ^a   Ardeleanu, Carmen ^b   Dema, Alis ^a   Sporea, I ^a   Cornianu, Marioara ^a   Lazǎr, Elena ^a   Vernic, Corina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

E cadherin; Gastric cancer; Immunohistochemical expression

Indexed keywords

CADHERIN;

ADULT; AGED; ARTICLE; CARCINOMA; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; STOMACH TUMOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 70449858841     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ZHOU Y. N., XU C. P., HAN B., LI M., QIAO L., FANG D. C., YANG J. M., Expression of E-cadherin and β-cateninin gastric carcinoma and its correlation with the clinicopathological features and patient survival, World J Gastroenterol, 2002, 8(6):987-993.
2. JOO Y. E., PARK C. S., KIM H. S., CHOI S. K., REW J. S., KIM S. J., Prognostic significance of E-cadherin/catenincomplex expression in gastric cancer, J Korean Med Sci, 2000, 15(6):655-666.
3. JAWHARI A., FARTHING M., PIGNATELLI M., The importance of the E-cadherin-catenin complex in the maintenance ofintestinal epithelial homoeostasis: more than intercellular glue, Gut, 1997, 41(5):581-584.
4. PIGNATELLI M., VESSEY C. J., Adhesion molecules: novel molecular tools in tumor pathology, Hum Pathol, 1994, 25(9):849-856.
5. GUZMÁN P., ARAYA J., VILLASECA M., ROA I., MELO A., MUÑOZ S., ROA J., Immunohistochemical expressionof the E-cadherin-catenin complex in gastric cancer, Rev Med Chil, 2006, 134(8):1002-1009.
6. WANG L., ZHANG F., WU P. P., JIANG X. C., ZHENG L., YU Y. Y., Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma, World J Gastroenterol, 2006, 12(26):4228-4231.
7. OKA H., SHIOZAKI H., KOBAYASHI K., INOUE M., TAHARA H., KOBAYASHI T., TAKATSUKA Y., MATSUYOSHI N., HIRANO S., TAKEICHI M., et al., Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis, Cancer Res, 1993, 53(7):1696-1701.
8. PIGNATELLI M., ANSARI T. W., GUNTER P., LIU D., HIRANO S., TAKEICHI M., KLÖPPEL G., LEMOINE N. R., Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage, J Pathol, 1994, 174(4):243-248.
9. JUNG I. M., CHUNG J. K., KIM Y. A., KIM J. E., HEO S. C., AHN Y. J., HWANG K. T., KIM B. G., LEE K. L., KIM C. W., KIM W. H., CHANG M. S., Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas, J Korean Med Sci, 2007, 22(5):855-861.
10. LEE H. J., LEE H. S., HUR K., KIM W. H., YANAGIHARA K., BECKER K. F., LEE K. U., YANG H. K., Tumor specificityand in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer, J Cancer Res Clin Oncol, 2007, 133(12):987-994.
11. AOKI R., YASUDA M., TORISU R., NAKAMOTO J., YAMAMOTO Y., ITO S., Relationship between lymph node metastasis andE-cadherin expression in submucosal invasive gastric carcinomas with gastric-phenotype, J Med Invest, 2007, 54(1-2):159-167.
12. Murata-Kamiya N., KURASHIMA Y., TEISHIKATA Y., YAMAHASHI Y., SAITO Y., HIGASHI H., ABURATANI H., AKIYAMA T., PEEK R. M. JR., AZUMA T., HATAKEYAMA M., Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells, Oncogene, 2007, 26(32):4617-4626.
13. ZHOU Y., RAN J., TANG C., WU J., HONGHUA L., XINGWEN L., NING C., QIAO L., Effect of celecoxib on E-cadherin,VEGF, microvessel density and apoptosis in gastric cancer, Cancer Biol Ther, 2007, 6(2):269-275.
14. MAYER B., JOHNSON J. P., LEITL F., JAUCH K. W., HEISS M. M., SCHILDBERG F. W., BIRCHMEIER W., FUNKE I.,E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration, Cancer Res, 1993, 53(7):1690-1695.
15. KARAYIANNAKIS A. J., SYRIGOS K. N., CHATZIGIANNI E., PAPANIKOLAOU S., KARATZAS G., E-cadherin expressionas a differentiation marker in gastric cancer, Hepatogastroenterology, 1998, 45(24):2437-2442.
16. SHUN C. T., WU M. S., LIN J. T., WANG H. P., HOUNG R. L., LEE W. J., WANG T. H., CHUANG S. M., An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer, Hepatogastroenterology, 1998, 45(22):944-949.
17. GABBERT H. E., MUELLER W., SCHNEIDERS A., MEIER S., MOLL R., BIRCHMEIER W., HOMMEL G., Prognostic valueof E-cadherin expression in 413 gastric carcinomas, Int J Cancer, 1996, 69(3):184-189.
18. CORREA P., Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer SocietyAward Lecture on Cancer Epidemiology and Prevention, Cancer Res, 1992, 52(24):6735-6740.
19. Ohene-Abuakwa Y., NODA M., PERENYI M., KOBAYASHI N., KASHIMA K., HATTORI T., PIGNATELLI M., Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer, J Pathol, 2000, 192(4):433-439.
20. XIANGMING C., HOKITA S., NATSUGOE S., TANABE G., BABA M., TAKAO S., KUROSHIMA K., AIKOU T., Cooccurrence ofreduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer, Oncology, 1999, 57(2):131-137.
21. BLOK P., CRAANEN M. E., DEKKER W., TYTGAT G. N., Loss of E-cadherin expression in early gastric cancer, Histopathology, 1999, 34(5):410-415.
22. SHUN C. T., WU M. S., LIN M. T., CHANG M. C., LIN J. T., CHUANG S. M., Immunohistochemical evaluation ofcadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection, Oncology, 2001, 60(4):339-345.
23. YI KIM D., KYOON JOO J., KYU PARK Y., YEOB RYU S., SOO KIM H., KYUN NOH B., HWA LEE K., HYUK LEE J.,E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis, J Surg Oncol, 2007, 96(5):429-435.
24. HARA A., YASHIMA K., YASUGI A., KODA M., KAWAGUCHI K., HARADA K., ANDACHI H., SHIOTA G., ITO H., MURAWAKI Y., Expression of Fhit, Mlh1, p16INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype, Oncol Rep, 2007, 18(3):553-559.
25. ARÉVALO F., MONGE E., MORALES D., E-cadherin molecularexpression in the diffuse and intestinal types of gastric adenocarcinoma. A report from Lima, Peru, Rev Esp Enferm Dig, 2007, 99(6):325-329.
26. CHAN A. O., LAM S. K., CHU K. M., LAM C. M., KWOK E., LEUNG S. Y., YUEN S. T., LAW S. Y., HUI W. M., LAI K. C., WONG C. Y., HU H. C., LAI C. L., WONG J., Soluble E-cadherin is a valid prognostic marker in gastric carcinoma, Gut, 2001, 48(6):808-811.
27. OUGOLKOV A., MAI M., TAKAHASHI Y., OMOTE K., BILIM V., SHIMIZU A., MINAMOTO T., Altered expression of beta-catenin and c-erbB-2 in early gastric cancer, J Exp Clin Cancer Res, 2000, 19(3):349-355.
28. FRIXEN U. H., BEHRENS J., SACHS M., EBERLE G., VOSS B., WARDA A., LÖCHNER D., BIRCHMEIER W., E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells, J Cell Biol, 1991, 113(1):173-185.
29. RUGGE M., CORREA P., DIXON M. F., HATTORI T., LEANDRO G., LEWIN K., RIDDELL R. H., SIPPONEN P., WATANABE H., Gastric dysplasia: the Padova international classification, Am J Surg Pathol, 2000, 24(2):167-176.
30. LEE J. H., KOH J. T., SHIN B. A., AHN K. Y., ROH J. H., KIM Y. J., KIM K. K., Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer, Int J Oncol, 2001, 18(2):355-361.
31. HE Q., CHEN J., LIN H. L., HU P. J., CHEN M. H., Expressionof peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases, Chin Med J (Engl), 2007, 120(17):1498-1504.
32. GABBERT H. E., MUELLER W., SCHNEIDERS A., MEIER S., MOLL R., BIRCHMEIER W., HOMMEL G., Prognostic valueof E-cadherin expression in 413 gastric carcinomas, Int J Cancer, 1996, 69(3):184-189.
33. GRABSCH H., TAKENO S., NOGUCHI T., HOMMEL G., GABBERT H. E., MUELLER W., Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome, Histopathology, 2001, 39(2):141-149.
34. ZHONG X. Y., ZHANG L. H., JIA S. Q., SHI T., NIU Z. J., DU H., ZHANG G. G., HU Y., LU A. P., LI J. Y., JI J. F., Positiveassociation of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer, Histopathology, 2008, 52(5):560-568.
35. ROBERTSON E. V., JANKOWSKI J. A., Genetics of gastro-esophageal cancer: paradigms, paradoxes, and prognostic utility, Am J Gastroenterol, 2008, 103(2):443-449.
36. Gamboa-Dominguez A., SEIDL S., Reyes-Gutierrez E., HERMANNSTÄDTER C., Quintanilla-Martinez L., BUSCH R., HÖFLER H., FEND F., LUBER B., Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer, J Clin Pathol, 2007, 60(7):756-761.